Ckd Bio (063160) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.022x

Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of 0.022x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.62 Billion ≈ $1.77 Million USD) by net assets (₩119.57 Billion ≈ $81.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 063160 company net worth for the company's overall valuation and market capitalisation.

Ckd Bio - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ckd Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency. Explore Ckd Bio cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Whitbread PLC LSE:WTB	0.105x
Nuveen New York Select Tax-Free Income Portfolio NYSE:NXN	N/A
Mcleod Russel India Limited NSE:MCLEODRUSS	-0.521x
Rothwell International Co. Limited KQ:900260	0.415x
Timberwell Bhd KLSE:7854	0.007x
Advani Hotels & Resorts (India) Limited NSE:ADVANIHOTR	0.016x
Botnia Gold AB (publ) ST:BOTX	-0.158x
Papilon Savunma Guvenlik Sistemleri IS:PAPIL	-0.031x

Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2025. View 063160 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩127.04 Billion ≈ $86.09 Million	₩-4.14 Billion ≈ $-2.81 Million	-0.033x	-130.45%
2024-12-31	₩131.01 Billion ≈ $88.78 Million	₩14.03 Billion ≈ $9.51 Million	0.107x	+282.39%
2023-12-31	₩123.02 Billion ≈ $83.37 Million	₩-7.22 Billion ≈ $-4.90 Million	-0.059x	-170.82%
2022-12-31	₩147.80 Billion ≈ $100.16 Million	₩-3.20 Billion ≈ $-2.17 Million	-0.022x	+40.47%
2021-12-31	₩161.49 Billion ≈ $109.44 Million	₩-5.88 Billion ≈ $-3.99 Million	-0.036x	-227.41%
2020-12-31	₩168.75 Billion ≈ $114.36 Million	₩4.82 Billion ≈ $3.27 Million	0.029x	-73.34%
2019-12-31	₩158.46 Billion ≈ $107.39 Million	₩16.99 Billion ≈ $11.51 Million	0.107x	+1.91%
2018-12-31	₩147.66 Billion ≈ $100.07 Million	₩15.54 Billion ≈ $10.53 Million	0.105x	-26.90%
2017-12-31	₩142.05 Billion ≈ $96.26 Million	₩20.45 Billion ≈ $13.86 Million	0.144x	+25.52%
2016-12-31	₩135.16 Billion ≈ $91.60 Million	₩15.50 Billion ≈ $10.50 Million	0.115x	+1.87%
2015-12-31	₩127.38 Billion ≈ $86.32 Million	₩14.34 Billion ≈ $9.72 Million	0.113x	+22.22%
2014-12-31	₩121.85 Billion ≈ $82.57 Million	₩11.22 Billion ≈ $7.61 Million	0.092x	+4.45%
2013-12-31	₩123.87 Billion ≈ $83.95 Million	₩10.92 Billion ≈ $7.40 Million	0.088x	-52.19%
2012-12-31	₩124.15 Billion ≈ $84.13 Million	₩22.90 Billion ≈ $15.52 Million	0.184x	+69.33%
2011-12-31	₩119.00 Billion ≈ $80.65 Million	₩12.96 Billion ≈ $8.79 Million	0.109x	-65.28%
2010-12-31	₩76.14 Billion ≈ $51.60 Million	₩23.89 Billion ≈ $16.19 Million	0.314x	-24.35%
2009-12-31	₩64.08 Billion ≈ $43.42 Million	₩26.57 Billion ≈ $18.01 Million	0.415x	+90.70%
2008-12-31	₩49.15 Billion ≈ $33.31 Million	₩10.69 Billion ≈ $7.24 Million	0.217x	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$47.62 Million

₩70.28 Billion KRW

Market Cap Rank

#22165 Global

#1381 in Korea

Share Price

₩12810.00

Change (1 day)

+0.08%

52-Week Range

₩12200.00 - ₩24500.00

All Time High

₩101057.67